Shilpa Medicare has been on the path of expansion ever since its inception in 1987.

Shilpa Medicare is one of the leaders in the Oncology and NDDS market and offers a complete range of products in this segment spanning across APIs, formulations both in terms of R&D and manufacturing capabilities. 

Further to consolidation in field of oncology API and formulations, we are striving to put in our efforts in field of novel drug delivery systems and biotech products along with widening our focus to other therapy areas. 

Shilpa Medicare is approved by stringent regulatory authorities such as USFDA, UKMHRA, EU, PMDA, ANVISA, Russia GMP, PMDA, GCC etc. with a recognized manufacturing set up and excellent scientific expert team in place, Shilpa Medicare is looking forward to collaborating under various business models like:

1. License and Supply.
2. Distribution.
3. Contract Development and Contract Manufacturing.
4. Technology Transfer along with API supply.